IPRs and Public Health: Lessons Learned Current Challenges The Way Forward
|
|
- Allan Ramsey
- 5 years ago
- Views:
Transcription
1 Local Pharmaceutical Production in Africa International Conference Cape Town, 4-6 April 2011 IPRs and Public Health: Lessons Learned Current Challenges The Way Forward Roger Kampf WTO Secretariat 1 Acknowledging that IPRs interact with public health at all levels Intellectual Property Rights Individual deals, projects, partnerships Policies & strategies for IP management at institutional level National policy settings for public-funded / public-interest research National legal framework & innovation policy International legal framework & cooperation 1
2 Where Do We Come From: the Interface between IPRs and Public Health Since last decade: Increased attention paid to impact of IPRs on innovation of and access to medicines Moved to centre of cross-cutting debate between separate policies TRIPS-related issues: IPR as an important factor for development of new medicines, but: concerns expressed about effect on prices Importance of flexibilities recognized, but: need to preserve balance of rights and obligations TRIPS as part of wider national and international action to address health problems Addressed at various levels: International organizations (WHO, WTO, WIPO, etc.) recognition of importance of cooperation Free Trade Agreements Domestically The Starting Point: Key TRIPS Provisions Objectives and principles balanced approach, adapted to domestic policy objectives Patents a range of flexibilities: Definition of patentable subject-matter Optional exclusions Disclosure requirements Permissible exceptions, including for experimental use and regulatory review purposes Compulsory licensing Exhaustion - national vs. international, freedom to choose Test data protection is mandatory, but how to protect is not prescribed Enforcement links to public health Transition periods for LDCs 2013 in general, 2016 in pharmaceutical sector 4 2
3 The Turning Point: Doha Declaration General statements: TRIPS Agreement does not and should not prevent Members from taking measures to protect public health. TRIPS can and should be interpreted and implemented in a manner supportive of Members right to protect public health and, in particular, to promote access to medicines for all Clarification of: compulsory licences: right to grant, freedom to determine grounds emergency situations: right to determine what constitutes a national emergency of other circumstance of extreme urgency exhaustion: freedom to establish own regime What the Doha Declaration Achieved Shaped framework for multilateral cooperation on IP and public health Supports governments to make use of TRIPS flexibilities Contributed to lower prices for certain medicines (first-line ARVs) Reinforced understanding that TRIPS supports a balanced and flexible IP framework responsive to broader policy agenda Led to adoption of Paragraph 6 System Extended LDC transition period 3
4 Paragraph 6: Identifying the Issue Members can issue compulsory licences for importation / domestic production Availability of supply from generic producers in third countries? Art. 31(f) requires production under compulsory licenses "predominantly for the supply of the domestic market of the Member Concern: countries with important generic industry obliged to provide full patent protection for pharma products since 2005 Need to address legal problem resulting from Art.31(f) conditions in exporting Member Paragraph 6: Proposing a Solution Removes a specific legal obstacle Consists of three derogations from: Art.31(f) for exporting Members, subject to conditions on transparency and safeguards Art.31(h) for importing Members provided paid in exporting Member on same products Art.31(f) for any LDC or developing country party to RTA where at least half are LDCs and share health problem in question Adopted in the light of General Council Chairman s statements Setting out several key shared understandings of Members on interpretation and implementation of the system 4
5 Remember: Paragraph 6 Is an additional flexibility made available to Members Addresses a health problem in the importing country and a legal problem in the exporting country Is applicable to narrowly defined situations Para.6 was never designed to and will never address all problems in the field of public health Facilitates imports of medicines produced under compulsory licence elsewhere Para.6 is primarily not about local production Has been used once so far Growing importance as full patent protection for pharmaceutical products is put in place in major exporting countries? Is it producing the expected results? Debate in TRIPS Council: narrow and broader aspects 9 Looking at the Broader Picture (1) Access to information about IPR status: Why: to determine freedom to operate in research and development and to design access and business strategies (e.g. R&D, tech transfer, production, procurement, etc.) What: information about specific technologies and products, specific markets, right holders, legal status of IPRs Who: important for key stakeholders, including policy makers, research institutions, business, procurement agencies, etc. Challenges: Easy access to reliable sources, providing regularly updated information Limited resources and lack of expertise Interdepartmental cooperation Language barriers 10 5
6 Looking at the Broader Picture (2) Other key factors which have been identified next to IPRs: Funding Partnerships Pricing (including transparency mechanisms) procurement practices Competition policies Taxes, tariffs and mark-ups Quality, safety and efficacy Available data: which, who and where 11 Local Production: Key IPR Aspects Compare national law & international obligations Consider TRIPS flexibilities Transition periods Licensing & Para.6 Syst. Determine IP policy & strategy on innovation & production Local Produc tion Analyse patent status Access to reliable data Cooperation Capacity 12 6
7 The WTO s Contribution Making available a forum for debate upon request by Members Examples: annual review of Paragraph 6 System; review of incentives to transfer technology (Art.66.2); enforcement trends Awareness raising Example: tailor-made regional and national workshops Provision of factual / technical information Individual requests Symposia Solving disputes Example: WT/DS114/R Note: WTO Secretariat has no mandate to interpret TRIPS provisions or to assess use of TRIPS flexibilities Lessons Learned & Way Forward (1) Need to ensure optimal outcomes within given policy space Shaped in part by IPR regime and IP management strategies IPRs cannot be considered in isolation They are to be treated as part of a much bigger puzzle Need to bear overall objective in mind = bringing medicines to patients Use of TRIPS flexibilities should not become an end in itself TRIPS implementation and use is not a mere transcript of provisions into national law Each country needs to reflect on contribution to domestic policy objectives (in particular social, economic and developmental) and, on that basis, decide on most appropriate approach Selected country experiences 14 7
8 Lessons Learned & Way Forward (2) More factual and technical information required in order to determine innovation and access policies and strategies Facilitate access to existing data Gather new data Coherence, cooperation and dialogue required at all levels to effectively respond to public health challenges and to practical needs: Multilateral: Doha Declaration as a benchmark and landmark reference point also for WHO (e.g. GSPOA) and WIPO (e.g. Development Agenda) Towards and effective and complementary partnership - trilateral process, symposia and beyond Regional: Make better use of scarce resources Domestic: Respond to multiple challenges (legislative changes, competent trade/ip/health authorities, participation in international bodies) Involve all relevant government departments and private sector 15 Some References WTO Webpage dedicated to public health: htm Basic introduction to TRIPS and pharmaceuticals, including patents and compulsory licensing Information regarding Paragraph 6 System, including notifications received, how to accept the Protocol, status of acceptances and national implementing legislation WTO Webpage dedicated to LDC needs assessment: Doha Declaration on TRIPS and Public Health (WT/MIN(01)/DEC/2) Implementation of paragraph 6 of the Doha Declaration on TRIPS and Public Health (WT/L/540 and Corr.1) Protocol Amending the TRIPS Agreement (WT/L/641) Extension of transition period for LDCs with respect to pharmaceutical products (IP/C/25) General extension of transition period for LDCs (IP/C/40) 16 8
The TRIPS Tightrope public health, innovation, incentives and access
International Federation of Pharmaceutical Manufacturers & Associations The TRIPS Tightrope public health, innovation, incentives and access Helsinki, 6 September 2013 1 IFPMA 2013 Definitions (I) Doha
More informationThe Interface Between Public Health, Trade & TRIPS: Current Work at the WTO and How it Relates to the Generic Industry
15 th Annual IGPA Conference Kyoto, Japan, 5 December 2012 The Interface Between Public Health, Trade & TRIPS: Current Work at the WTO and How it Relates to the Generic Industry Roger Kampf, WTO Secretariat
More informationThe TRIPS Agreement and Patentability Criteria
WHO-WIPO-WTO Technical Workshop on Patentability Criteria Geneva, 27 October 2015 The TRIPS Agreement and Patentability Criteria Roger Kampf WTO Secretariat 1 Trilateral Cooperation: To Build Capacity,
More informationWTO NEGOTIATIONS ON TRIPS AND PUBLIC HEALTH: AN OVERVIEW. Jayashree Watal WTO Secretariat
WTO NEGOTIATIONS ON TRIPS AND PUBLIC HEALTH: AN OVERVIEW Jayashree Watal WTO Secretariat Outline Background to discussions in the TRIPS Council, including WHO-WTO Workshop on Differential Pricing and Financing
More informationEstablishing a Development Agenda for the World Intellectual Property Organization
1 Establishing a Development Agenda for the World Intellectual Property Organization to be submitted by Brazil and Argentina to the 40 th Series of Meetings of the Assemblies of the Member States of WIPO
More information19 Progressive Development of Protection Framework for Pharmaceutical Invention under the TRIPS Agreement Focusing on Patent Rights
19 Progressive Development of Protection Framework for Pharmaceutical Invention under the TRIPS Agreement Focusing on Patent Rights Research FellowAkiko Kato This study examines the international protection
More informationDr. Biswajit Dhar Professor, Jawaharlal Nehru University, India and Member DA9 Advisory Board
Dr. Biswajit Dhar Professor, Jawaharlal Nehru University, India and Member DA9 Advisory Board Intellectual Property Rights in Preferential Trade Agreements Many Preferential Trade Agreements (PTAs) adopted
More informationGENEVA WIPO GENERAL ASSEMBLY. Thirty-First (15 th Extraordinary) Session Geneva, September 27 to October 5, 2004
WIPO WO/GA/31/11 ORIGINAL: English DATE: August 27, 2004 WORLD INTELLECTUAL PROPERT Y O RGANI ZATION GENEVA E WIPO GENERAL ASSEMBLY Thirty-First (15 th Extraordinary) Session Geneva, September 27 to October
More informationThe 45 Adopted Recommendations under the WIPO Development Agenda
The 45 Adopted Recommendations under the WIPO Development Agenda * Recommendations with an asterisk were identified by the 2007 General Assembly for immediate implementation Cluster A: Technical Assistance
More informationWIPO Development Agenda
WIPO Development Agenda William New William New Intellectual Property Watch Geneva wnew@ip-watch.ch WIPO Development Agenda* Background to Agreement 2007 Development Agenda Availability of Information
More informationWIPO Development Agenda
WIPO Development Agenda 2 The WIPO Development Agenda aims to ensure that development considerations form an integral part of WIPO s work. As such, it is a cross-cutting issue which touches upon all sectors
More informationTRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY ACCESS TO MEDICINE: Exploitation of pharmaceutical patents: compulsory licences SESSION 4
TRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY 1 12 14 March 2012 Pretoria, South Africa SESSION 4 ACCESS TO MEDICINE: COMMERCIALISATION, DISTRIBUTION, COMPETITION ----------------- Exploitation
More informationStanding Committee on the Law of Patents Twenty-Sixth Session
Standing Committee on the Law of Patents Twenty-Sixth Session Marco M. ALEMAN Director, Patent Law Division, WIPO Geneva, July 3 to 6, 2017 SCP/26/5 CONSTRAINTS FACED BY DEVELOPING COUNTRIES AND LEAST
More informationStanding Committee on the Law of Patents
E SCP/24/4 ORIGINAL: ENGLISH DATE: JUNE 29, 2016 Standing Committee on the Law of Patents Twenty-Fourth Session Geneva, June 27 to 30, 2016 PROPOSAL BY THE AFRICAN GROUP FOR A WIPO WORK PROGRAM ON PATENTS
More informationDraft Plan of Action Chair's Text Status 3 May 2008
Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background
More informationTRIPS, FTAs and BITs: Impact on Domestic IP- and Innovation Strategies in Developing Countries
Innovation, Creativity and IP Policy: An Indo-European Dialogue TRIPS, FTAs and BITs: Impact on Domestic IP- and Innovation Strategies in Developing Countries Henning Grosse Ruse NUJS & MPI Collaborative
More informationAccess to Medicines, Patent Information and Freedom to Operate
TECHNICAL SYMPOSIUM DATE: JANUARY 20, 2011 Access to Medicines, Patent Information and Freedom to Operate World Health Organization (WHO) Geneva, February 18, 2011 (preceded by a Workshop on Patent Searches
More information372 index. predominantly for supply of domestic market 113, 132 3, 184 5, 186; remedying anticompetitive
INDEX acceding countries 23 Access to Medicines, Patent Information and Freedom to Operate (WHO/ WIPO/WTO) 195 Access to Medicines: Pricing and Procurement Practices (WHO/WIPO/WTO) 195 Agreement on Trade-Related
More informationGlobalizing IPR Protection: How Important Might RTAs Be?
Globalizing IPR Protection: How Important Might RTAs Be? Keith Maskus, University of Colorado Boulder (keith.maskus@colorado.edu) NAS Innovation Policy Forum National and International IP Policies and
More informationVirtual Mentor American Medical Association Journal of Ethics December 2006, Volume 8, Number 12:
Virtual Mentor American Medical Association Journal of Ethics December 2006, Volume 8, Number 12: 834-838. Health law Intellectual property and access to medicine for the poor by Tara Leevy, LLB, LLM India
More informationB) Issues to be Prioritised within the Proposed Global Strategy and Plan of Action:
INTERGOVERNMENTAL WORKING GROUP ON PUBLIC HEALTH, INNOVATION AND INTELLECTUAL PROPERTY EGA Submission to Section 1 Draft Global Strategy and Plan of Action The European Generic Medicines Association is
More informationFlexibilities in the Patent System
Flexibilities in the Patent System Dr. N.S. Gopalakrishnan Professor, HRD Chair on IPR School of Legal Studies, Cochin University of Science & Technology, Cochin, Kerala 1 Introduction The Context Flexibilities
More informationIP Strategies to Enhance Competitiveness: India s Experience
IP Strategies to Enhance Competitiveness: India s Experience N. N. Prasad Wednesday July 15, 2009 Innovation in Brazil, India and South Africa: A New Drive for Economic Growth and Development Strategy
More informationWIPO-WTO Colloquium for Teachers of Intellectual Property
E WORLD TRADE ORGANIZATION COLLOQUIUM WIPO-WTO/COL/18/INF1.PROV ORIGINAL: ENGLISH DATE: JANUARY 2018 WIPO-WTO Colloquium for Teachers of Intellectual Property organized by the World Intellectual Property
More informationTRIPs & PATENTS. In 1899, Mr. Charles H. Duell, Director of US Patent office said Everything that can be invented, has (already) been invented.
TRIPs & PATENTS Dr.Gopakumar G. Nair In 1899, Mr. Charles H. Duell, Director of US Patent office said Everything that can be invented, has (already) been invented. The events thereafter proved that inventions
More informationWORLD TRADE ORGANIZATION ADVANCED COURSE. WIPO-WTO/ADV/ACAD/13/INF1.PROV ORIGINAL: English DATE: XXXX
E WORLD TRADE ORGANIZATION ADVANCED COURSE -/ADV/ACAD/13/INF1.PROV ORIGINAL: English DATE: XXXX Last updated 2 December 2013 - Advanced Course on Intellectual Property for Government Officials organized
More informationMarket Access and Environmental Requirements
Market Access and Environmental Requirements THE EFFECT OF ENVIRONMENTAL MEASURES ON MARKET ACCESS Marrakesh Declaration - Item 6 - (First Part) 9 The effect of environmental measures on market access,
More informationWORLD TRADE ORGANIZATION
WORLD TRADE ORGANIZATION Activity Sheet TITLE OF THE EVENT / Advanced Course on Intellectual Property for Government Officials VENUE AND DATES Geneva, Switzerland, 10-21 March 2014 Course description This
More informationAn Essential Health and Biomedical R&D Treaty
An Essential Health and Biomedical R&D Treaty Submission by Health Action International Global, Initiative for Health & Equity in Society, Knowledge Ecology International, Médecins Sans Frontières, Third
More informationWIPO Sub-Regional Workshop on Patent Policy and its Legislative Implementation
WIPO Sub-Regional Workshop on Patent Policy and its Legislative Implementation Topic 2: The Patent system Policy objectives of the patent system Ways and means to reach them Marco M. ALEMAN Deputy Director,
More informationCarnegie Endowment for International Peace
Carnegie Endowment for International Peace How the U.S. and India could Collaborate to Strengthen Their Bilateral Relationship in the Pharmaceutical Sector Second Panel: Exploring the Gilead-India Licensing
More informationWHO workshop on IP and Vaccines. Geneva 19 th -20 th April Introduction to the IP issues Christopher Garrison Consultant to WHO
WHO workshop on IP and Vaccines Geneva 19 th -20 th April 2004 Introduction to the IP issues Christopher Garrison Consultant to WHO Vaccine access, R&D and technology transfer issues are intimately linked
More informationIntellectual Property
Intellectual Property Johnson & Johnson believes that the protection of intellectual property (IP) is essential to rewarding innovation and promoting medical advances. We are committed: to raising awareness
More informationThe role of IP and other enabling factors for innovation and uptake of climate relevant technologies WIPO Green technology database and services
The role of IP and other enabling factors for innovation and uptake of climate relevant technologies WIPO Green technology database and services Anja von der Ropp Program Officer, Global Challenges Division,
More informationCommittee on Development and Intellectual Property (CDIP)
E CDIP/6/4 REV. ORIGINAL: ENGLISH DATE: NOVEMBER 26, 2010 Committee on Development and Intellectual Property (CDIP) Sixth Session Geneva, November 22 to 26, 2010 PROJECT ON INTELLECTUAL PROPERTY AND TECHNOLOGY
More informationBIPF Munich. South Africa Enforcement of Pharmaceutical Patents and the New Draft IP Policy
BIPF 2014 - Munich South Africa Enforcement of Pharmaceutical Patents and the New Draft IP Policy Russell Bagnall Danie Dohmen 1 OVERVIEW Enforcement of Pharmaceutical Patents The Role Players Compulsory
More informationMcLEAN SIBANDA. Senior Patent Attorney Innovation Fund WIPO LIFESCIENCES SYMPOSIUM: PUBLIC SECTOR INTELLECTUAL PROPERTY MANAGEMENT
FRAMING A NATIONAL POLICY AND LEGISLATION FOR MANAGING IPR RESULTING FROM PUBLICLY FINANCED RESEARCH & DEVELOPMENT McLEAN SIBANDA Senior Patent Attorney Innovation Fund mclean@nrf.ac.za WIPO LIFESCIENCES
More informationTopic 2: Patent-related Flexibilities in Multilateral Treaties and Their Importance for Developing Countries and LDCs
Topic 2: Patent-related Flexibilities in Multilateral Treaties and Their Importance for Developing Countries and LDCs McLean Sibanda Chief Executive Officer - The Innovation Hub Second WIPO Inter-Regional
More informationRole of Patents in Green Technology Transfer in the Context of Climate Change
Role of Patents in Green Technology Transfer in the Context of Climate Change Wanna Tanunchaiwatana Manager, Technology UN Climate Change Secretariat WIPO conference on Intellectual Property and Public
More informationElements of a global strategy and plan of action
INTERGOVERNMENTAL WORKING GROUP A/PHI/IGWG/1/5 ON PUBLIC HEALTH, INNOVATION AND 8 December 2006 INTELLECTUAL PROPERTY Agenda item 2.3 Elements of a global strategy and plan of action Progress to date in
More informationGenetic Resources and Intellectual Property: Recent developments under the Convention on Biological Diversity
Genetic Resources and Intellectual Property: Recent developments under the Convention on Biological Diversity 15 September, 2004 Secretariat of the Convention on Biological Diversity Dan B. Ogolla OUTLINE
More informationUNCTAD Ad Hoc Expert Meeting on the Green Economy: Trade and Sustainable Development Implications November
UNCTAD Ad Hoc Expert Meeting on the Green Economy: Trade and Sustainable Development Implications 8-10 November Panel 3: ENHANCING TECHNOLOGY ACCESS AND TRANSFER Good morning Ladies and Gentlemen. On behalf
More informationSEMINAR: INTELLECTUAL PROPERTY ARRANGEMENTS: IMPLICATIONS FOR DEVELOPING COUNTRY PRODUCTIVE CAPABILITIES IN THE SUPPLY OF ESSENTIAL MEDICINES.
SEMINAR: INTELLECTUAL PROPERTY ARRANGEMENTS: IMPLICATIONS FOR DEVELOPING COUNTRY PRODUCTIVE CAPABILITIES IN THE SUPPLY OF ESSENTIAL MEDICINES Report The two-day seminar was opened by Mr. Khalil Hamdani,
More informationSustainable development
Guillaume Henry Joël Ruet Matthieu Wemaëre Sustainable development & INTELLECTUAL PROPERTY Access to technologies in developing countries Overview Sustainable development, this meta-project that aims to
More informationIntellectual Property and Public Health - International Framework and Recent Developments in WIPO: SCP and CDIP
Intellectual Property and Public Health - International Framework and Recent Developments in WIPO: SCP and CDIP WTO-ESCAP-IIUM REGIONAL WORKSHOP ON IP AND PUBLIC HEALTH AND ENVIRONMENT PLOICY FOR THE ASIAN
More information1. Recognizing that some of the barriers that impede the diffusion of green technologies include:
DATE: OCTOBER 21, 2011 WIPO GREEN THE SUSTAINABLE TECHNOLOGY MARKETPLACE CONCEPT DOCUMENT EXECUTIVE SUMMARY 1. Recognizing that some of the barriers that impede the diffusion of green technologies include:
More informationthe Companies and Intellectual Property Commission of South Africa (CIPC)
organized by the Companies and Intellectual Property Commission of South Africa (CIPC) the World Intellectual Property Organization (WIPO) the International Criminal Police Organization (INTERPOL) the
More informationGlobal strategy and plan of action on public health, innovation and intellectual property
SIXTY-FIRST WORLD HEALTH ASSEMBLY WHA61.21 Agenda item 11.6 24 May 2008 Global strategy and plan of action on public health, innovation and intellectual property The Sixty-first World Health Assembly,
More informationTRIPS FLEXIBILITIES AND ACCESS TO MEDICINES
TRIPS FLEXIBILITIES AND ACCESS TO MEDICINES A European Approach Acknowledgements We are grateful to Ellen t Hoen for reviewing an earlier version of this brochure. Publisher Health Action International
More informationMultilateral negotiations on IP - Traditional Knowledge and Genetic resources
Multilateral negotiations on IP - Traditional Knowledge and Genetic resources Alejandro Neyra Lima, March 2010 Intellectual property multilateral negotiations WIPO treaties/processes WTO: TRIPS Agreement
More informationTRIPS and Access to Medicines. The Story so far
TRIPS and Access to Medicines The Story so far TRIPS and Access to Medicines : A brief history 1981: HIV first clinically observed 1982-83: Named AIDS 1984: Discovery that it is caused by a virus 1986:
More informationStanding Committee on the Law of Patents
E SCP/15/INF/2 ORIGINAL: ENGLISH DATE: JULY 20, 2010 Standing Committee on the Law of Patents Fifteenth Session Geneva, October 11 to 15, 2010 STATUS OF WORK RELATING TO THE NON-EXHAUSTIVE LIST OF ISSUES
More informationNON-PAPER ON THE PROJECT ON INTELLECTUAL PROPERTY AND TECHNOLOGY TRANSFER COMMON CHALLENGES BUILDING SOLUTIONS (DOCUMENT CDIP/4/7)
(E) 12/03/2010 NON-PAPER ON THE PROJECT ON INTELLECTUAL PROPERTY AND TECHNOLOGY TRANSFER COMMON CHALLENGES BUILDING SOLUTIONS (DOCUMENT CDIP/4/7) prepared by the Secretariat page i Table of Contents BACKGROUND...
More informationWIPO Intergovernmental Committee on Intellectual Property, Genetic Resources, Traditional Knowledge and Folklore, Sixth Session, March 2004
WIPO Intergovernmental Committee on Intellectual Property, Genetic Resources, Traditional Knowledge and Folklore, Sixth Session, 15-19 March 2004 Statement by the Secretariat of the Convention on Biological
More informationStatement by the BIAC Committee on Technology and Industry on THE IMPACT OF INTELLECTUAL PROPERTY PROTECTION ON INNOVATION AND TECHNOLOGY DEVELOPMENT
Business and Industry Advisory Committee to the OECD OECD Comité Consultatif Economique et Industriel Auprès de l l OCDE Statement by the BIAC Committee on Technology and Industry on THE IMPACT OF INTELLECTUAL
More informationPROTECTION OF INTELLECTUAL PROPERTY
Chapter 12 PROTECTION OF INTELLECTUAL PROPERTY OVERVIEW OF RULES In today s economic environment, intangible assets are becoming increasingly important. These assets, which are the result of human intellectual
More informationProtecting Intellectual Property under TRIPS, FTAs and BITs: Conflicting Regimes or Mutual Coherence?
Protecting Intellectual Property under TRIPS, FTAs and BITs: Conflicting Regimes or Mutual Coherence? Henning Große Ruse International Investment Treaty Law and Arbitration Conference Sydney, 19-20 February
More informationAn overview of India's approach to key IP issues at home and abroad. Dr. Bona Muzaka King s College London
An overview of India's approach to key IP issues at home and abroad Dr. Bona Muzaka King s College London valbona.muzaka@kcl.ac.uk Why Intellectual Property? Why India? UNITAID (patent pools since 2008,
More informationThe Green Economy: Trade and Sustainable Development Implications. From Rio to Rio:Technology Transfer, Innovation and Intellectual Property
Ad Hoc Expert Meeting on The Green Economy: Trade and Sustainable Development Implications Geneva, Switzerland. 8-10 Nov 2011 From Rio to Rio:Technology Transfer, and Intellectual Property By Mr. Ahmed
More informationAAAS Project on Science and Intellectual Property in the Public Interest
AAAS Project on Science and Intellectual Property in the Public Interest Bringing a public interest perspective to science and intellectual property issues, by: Examining the effects of IPRs on science
More informationOECD Innovation Strategy: Key Findings
The Voice of OECD Business March 2010 OECD Innovation Strategy: Key Findings (SG/INNOV(2010)1) BIAC COMMENTS General comments BIAC has strongly supported the development of the horizontal OECD Innovation
More informationOperational Objectives Outcomes Indicators
UNEP/CBD/BS/COP-MOP/5/17 Page 106 ELEMENTS OF STRATEGIC PLAN FOR THE CARTAGENA PROTOCOL ON BIOSAFETY VISION Biological diversity is adequately protected from any adverse effects of living modified organisms
More informationCOMMENTS MADE BY MEMBERS AND OBSERVERS OF THE SCP ON DOCUMENT SCP/14/4 (TRANSFER OF TECHNOLOGY)
COMMENTS MADE BY MEMBERS AND OBSERVERS OF THE SCP ON DOCUMENT SCP/14/4 (TRANSFER OF TECHNOLOGY) I. 15 th session of the SCP, October 11-15, 2010 [Excerpts from the Report (document SCP/15/6)] 1. Discussions
More informationSubmission to the Productivity Commission inquiry into Intellectual Property Arrangements
Submission to the Productivity Commission inquiry into Intellectual Property Arrangements DECEMBER 2015 Business Council of Australia December 2015 1 Contents About this submission 2 Key recommendations
More informationThe Contribution of Intellectual Property to Facilitating the Transfer of Environmentally Sound Technology
Report The Contribution of Intellectual Property to Facilitating the Transfer of Environmentally Sound Technology Tuesday, 12 May 2015, Java Hill, Crozet, France Nina Fink In the line of the use and transfer
More informationSubregional Seminar on the Legal Protection of Biotechnology and Genetic Resources Banska Bystrica, May 2 and 3, Access and Benefit Sharing
Subregional Seminar on the Legal Protection of Biotechnology and Genetic Resources Banska Bystrica, May 2 and 3, 2007 Access and Benefit Sharing Hans Georg Bartels 1 Overview The Context The Patent system
More informationTHE WIPO DEVELOPMENT AGENDA. New York February 2011
THE WIPO DEVELOPMENT AGENDA New York 23-24 February 2011 What Is the WIPO Development Agenda? The Development Agenda in WIPO is a Member Statesdriven process, which seeks to place the development dimension
More informationWorld Intellectual Property Organization. Topic C: Healthcare and Pharmacological Patents
World Intellectual Property Organization Topic C: Healthcare and Pharmacological Patents The policy balance between encouraging innovation and ensuring the widespread enjoyment of the social benefit of
More informationPATENT PROTECTION FOR PHARMACEUTICAL PRODUCTS IN CANADA CHRONOLOGY OF SIGNIFICANT EVENTS
PRB 99-46E PATENT PROTECTION FOR PHARMACEUTICAL PRODUCTS IN CANADA CHRONOLOGY OF SIGNIFICANT EVENTS Margaret Smith Law and Government Division 30 March 2000 Revised 31 May 2000 PARLIAMENTARY RESEARCH BRANCH
More informationESTABLISHING A DEVELOPMENT AGENDA FOR THE WORLD INTELLECTUAL PROPERTY ORGANIZATION (WIPO): COMMENTARY ON PROPOSAL BY ARGENTINA AND BRAZIL
SC/TADP/AN/IP/3 Original: English ESTABLISHING A DEVELOPMENT AGENDA FOR THE WORLD INTELLECTUAL PROPERTY ORGANIZATION (WIPO): COMMENTARY ON PROPOSAL BY ARGENTINA AND BRAZIL TABLE OF CONTENTS I. INTRODUCTION...1
More informationTECHNOLOGY TRANSFER IN THE UNFCCC AND OTHER INTERNATIONAL LEGAL REGIMES:
TECHNOLOGY TRANSFER IN THE UNFCCC AND OTHER INTERNATIONAL LEGAL REGIMES: THE CHALLENGE OF SYSTEMIC INTEGRATION 1 2010, International Council on Human Rights Policy Not for public distribution, attribution
More informationPOSITION PAPER. GREEN PAPER From Challenges to Opportunities: Towards a Common Strategic Framework for EU Research and Innovation funding
POSITION PAPER GREEN PAPER From Challenges to Opportunities: Towards a Common Strategic Framework for EU Research and Innovation funding Preamble CNR- National Research Council of Italy shares the vision
More informationWIPO: Working on the balance
WIPO: Working on the balance Use and Abuse of IP and Related Rights : Getting the Right Balance Second Session October 17, 2010 Matthew Bryan, Director, Patent Cooperation Treaty Legal Division Trolls
More informationAmericas Trade and Sustainable Development Forum (ATSDF) November 2003, Miami. Trade, Knowledge and Intellectual Property Rights Thematic Tent
Americas Trade and Sustainable Development Forum (ATSDF) 17-18 November 2003, Miami Trade, Knowledge and Intellectual Property Rights Thematic Tent CONCLUSIONS On behalf of the Trade, Knowledge and Intellectual
More informationThe stakes within diverse global policy deliberations concerning treatment of Intellectual Property related to standard-setting
The stakes within diverse global policy deliberations concerning treatment of Intellectual Property related to standard-setting ANSI CMF/ICSCA Meeting Agenda 3.4 Miami, Florida: April 10, 2008 Presented
More informationTransparency in Negotiations Involving Norms for Knowledge Goods. What Should USTR Do? 21 Specific Recommendations
What Should USTR Do? 21 Specific Recommendations July 22, 2009 To: United States Trade Representative From: Electronic Frontier Foundation (EFF) Essential Action Knowledge Ecology International (KEI) Public
More informationCOMPLIANCE OF CANADA S UTILITY DOCTRINE WITH INTERNATIONAL MINIMUM STANDARDS OF PATENT PROTECTION
COMPLIANCE OF CANADA S UTILITY DOCTRINE WITH INTERNATIONAL MINIMUM STANDARDS OF PATENT PROTECTION Jerome H. Reichman Duke Law School April 11, 2014 1 E. Richard Gold & Michael Short The Promise of the
More informationp. 21 p. 45 p. 87 p. 89
Preface Treaties Relating to Food and Protection of Biotechnology p. 1 Introduction p. 3 General Outline p. 3 Structure of the Study p. 9 Delimitations p. 10 Food, Biotechnology and Intellectual Property
More informationSpotlight: Buenos Aires Ministerial Conference 32
Our year Our year The WTO held its 11 th Ministerial Conference in Buenos Aires in 2017, the first time such a meeting has been held in South America. The Conference ended with the adoption of a number
More informationMagdalena Krawczyk. Compulsory Licensing of Pharmaceuticals since the Doha Declaration a Public Health Triumph or Failure? Abstract.
Zeszyty Naukowe Towarzystwa Doktorantów UJ Nauki Społeczne, Numer 15 (4/2016) Magdalena Krawczyk Jagiellonian University Faculty of Law and Administration The Intellectual Property Law Chair e-mail: magda.krawczyk@doctoral.uj.edu.pl
More informationUNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview
UNITAID The HIV/AIDS Medicines Patent Pool Initiative Overview December 2009 UNITAID Mission UNITAID's Mission Scale up access to treatment for HIV/AIDS, malaria and TB Leverage price reductions of quality
More informationTRIPS-Plus Provisions and Access to Technologies:
TRIPS-Plus Provisions and Access to Technologies: Implications for the Trans-Pacific Partnership Walter G. Park, American University 11 May 2012 Outline Notion of Optimal IPRs IPRs and Technology Transfer
More informationNote by the secretariat * Summary
UNITED NATIONS Distr. GENERAL 20 May 2008 Original: ENGLISH SUBSIDIARY BODY FOR IMPLEMENTATION Twenty-eighth session Bonn, 4 13 June 2008 Item 6 of the provisional agenda Development and transfer of technologies
More informationAfrican Civil Society Meeting
African Civil Society Meeting Intergovernmental Working Group on Intellectual Property, Innovation and Health Topic: Considering Domestic Manufacturing Issues Nairobi Kenya 28-29 August 2007 DR W.O. WANYANGA
More informationTBT Provisions in RTAs: Do they go beyond the TBT Agreement?
TBT Provisions in RTAs: Do they go beyond the TBT Agreement? Xinyi Li Trade Policies Review Division, WTO Secretariat 12 th ARTNeT Capacity Building Workshop December 2016 1 Motives and Objectives TBT
More informationWORKSHOP ON TRADE AND PUBLIC HEALTH. Organized by the WTO Secretariat. in collaboration with the Secretariats of WHO and WIPO
WORKSHOP ON TRADE AND PUBLIC HEALTH Organized by the WTO Secretariat in collaboration with the Secretariats of WHO and WIPO Geneva, 6-10 November 2017 Programme Monday, 6 November 2017 08h30 09h00 09h00
More informationDifferent Options for ABS in Relation to Marine Genetic Resources in ABNJ
Different Options for ABS in Relation to Marine Genetic Resources in ABNJ Seminar on Conservation and Sustainable Use of Marine Biodiversity Beyond National Jurisdiction Thomas Greiber (LL.M.) Senior Legal
More informationWhat We Heard Report Inspection Modernization: The Case for Change Consultation from June 1 to July 31, 2012
What We Heard Report Inspection Modernization: The Case for Change Consultation from June 1 to July 31, 2012 What We Heard Report: The Case for Change 1 Report of What We Heard: The Case for Change Consultation
More informationEnforcement of Intellectual Property Rights Frequently Asked Questions
EUROPEAN COMMISSION MEMO Brussels/Strasbourg, 1 July 2014 Enforcement of Intellectual Property Rights Frequently Asked Questions See also IP/14/760 I. EU Action Plan on enforcement of Intellectual Property
More informationPractical measures to encourage the diffusion of green technologies: Licensing Fast tracking of green patents The GreenXchange Platform
Practical measures to encourage the diffusion of green technologies: Licensing Fast tracking of green patents The GreenXchange Platform Ahmed Abdel Latif Senior Programme Manager Innovation, Technology
More informationBEYOND FTA NEGOTIATIONS IMPLEMENTING THE NEW GENERATION OF INTELLECTUAL PROPERTY OBLIGATIONS *
David Vivas-Eugui y Johanna von Braun, ICTSD Taller Regional para el Desarrollo de un Modelo sobre Datos de Prueba Costa Rica, 21 y 22 de Agosto 2006 ICTSD/UNCTAD/CINPE BEYOND FTA NEGOTIATIONS IMPLEMENTING
More informationUniversity IP and Technology Management. University IP and Technology Management
University IP and Technology Management Yumiko Hamano WIPO University Initiative Program Innovation Division WIPO WIPO Overview IP and Innovation University IP and Technology Management Institutional IP
More informationUN GA TECHNOLOGY DIALOGUES, APRIL JUNE
UN GA TECHNOLOGY DIALOGUES, APRIL JUNE 2014 Suggestions made by participants regarding the functions of a possible technology facilitation mechanism Background document by the Secretariat for the fourth
More informationTrade facilitation in the context of the SPS Agreement
Trade facilitation in the context of the SPS Agreement WCO Regional Workshop on Strategic Initiatives for Trade Facilitation - Mercator Programme Christiane Wolff Agriculture and Commodities Division World
More informationThe relationship between the IR, the WTO, UPOV Convention and WIPO. Jorge Cabrera Medaglia
The relationship between the IR, the WTO, UPOV Convention and WIPO Jorge Cabrera Medaglia Structure of the study 1. Factual overview of relevant developments and provisions and their relationship with
More informationThe UK Government Response to The Report of the Commission on Intellectual Property Rights "Integrating Intellectual Property Rights and Development
The UK Government Response to The Report of the Commission on Intellectual Property Rights "Integrating Intellectual Property Rights and Development Policy" The UK Government Response to the Report of
More informationTERMS OF REFERENCE. Preparation of a Policymakers Handbook on E-Commerce and Digital Trade for LDCs, small states and Sub-Saharan Africa
TERMS OF REFERENCE Reference: Post Title: NBCWG0923 Preparation of a Policymakers Handbook on E-Commerce and Digital Trade for LDCs, small states and Sub-Saharan Africa Project Location: home-based with
More informationDistinguished Co-facilitators, Ambassadors, delegates and representatives from capitals,
Joint Session of FfD and the Post-2015 Development Agenda 22 April, 2015 Statement by Ambassador Guilherme de Aguiar Patriota, DPR of Brazil and co-moderator of the Structured Dialogues on Technology Facilitation
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 13.10.2004 COM(2004) 668 final COMMUNICATION FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND
More informationRegional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities
REPUBLIC OF SOUTH AFRICA Regional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities Topic 15: The Impact of National Exhaustion of Rights on the
More information